suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
Conditions: COVID-19; Virus Diseases; Corona Virus Infection; LRTI; Lower Respiratory Tract Infection Viral Interventions: Drug: Anakinra; Drug: trimethoprim/sulfamethoxazole Sponsor: Hellenic Institute for the Study of Sepsis Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials